Paul Janssen was born 100 years ago
Probably, the most creative and productive pharmaceutical chemist of all time, Dr. Paul Adriaan Jan Janssen, was born 100 years
Tag: HPBCD
Tailoring cyclodextrin platforms for nanomolar range fluorescence detection of 1-hydroxypyrene as biomarker of polycyclic aromatic hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are widespread combustion-derived pollutants, and 1-hydroxypyrene (1HOPy) is the standard biomarker used to track human exposure
HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient
REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,
Fast-Dissolving HPβCD Nanofibers with a combination of 3 drugs: A New Solution for Pain Relief
Researchers from the United States 🇺🇸 developed fast-dissolving HPβCD nanofibers containing a three-drug combination of aspirin, paracetamol, and caffeine commonly
How Cyclodextrins Improve Red Wine Colour During Ageing?
Wine is a remarkably complex chemical system. Once fermentation begins, hundreds of compounds continuously react, transform and interact with each
Cyclodextrin-Based Formulations to Improve Solubility of Poorly Soluble Drugs
This chapter offers a detailed overview of the structural features, different types, and chemical modifications of CDs and their derivatives,
Can a Cyclodextrin Really Stop Body Odor by Quorum Quenching?
I recently came across an interesting commercial deodorant that caught my attention for a rather unusual reason: it claims to
Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
The effects of native and modified CDs in human renal proximal tubule cells was studied using complementary imaging, flow cytometry,
Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
Researchers from Italy and Argentina developed a HPBCD-based oral solution of ursodeoxycholic acid (UDCA), a bile acid widely used for